Results 41 to 50 of about 28,269 (176)

The important lessons lurking in the history of meningococcal epidemiology

Expert Review of Vaccines
Introduction The epidemiology of invasive meningococcal disease (IMD), a rare but potentially fatal illness, is typically described as unpredictable and subject to sporadic outbreaks.Areas covered Meningococcal epidemiology and vaccine use during the ...
Ray Borrow, Jamie Findlow
doaj   +1 more source

Systemic manifestations in the course of meningococcal disease [PDF]

Vojnosanitetski Pregled, 2009
Background/Aim. Meningococcal disease most often manifests itself as meningitis or sepsis. During the course of these diseases, other clinical events sometimes develop such as pneumonia, pericarditis, arthritis, and they are referred to as extrameningeal
Dulović Olga, Stevanović Goran, Milošević Branko, Gvozdenović Eleonora, Dokić Ljubiša, Popović Nataša, Nikolić Svetlana, Pavlović Milorad   +7 more
doaj   +1 more source

Trained Immunity in Childhood Vaccination

Acta Paediatrica, EarlyView.
Trained immunity as an emerging concept in paediatric vaccinology. Trained immunity links vaccine stimuli through epigenetic and metabolic reprogramming to enhanced innate immune cell function, thereby strengthening protection against diverse pathogens while promoting adaptive immune responses through more efficient antigen presentation and co ...
ChenRongRong Cai, Lubnaa Hossenbaccus, Eva Kaufmann   +2 more
wiley   +1 more source

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors

Internal Medicine Journal, EarlyView.
Abstract Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence‐based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or planning to receive, complement inhibitors for neurological conditions in the Australian setting.
Katherine A. Buzzard, Michael Barnett, Heidi Beadnall, Mirasol Forcadela, Lesley‐Ann Hall, Victoria G. Hall, Todd Hardy, Danny Hsu, Paul Kinsella, Mastura Monif, Sudarshini Ramanathan, Stephen W. Reddel, Sean Riminton, Douglas F. Johnson   +13 more
wiley   +1 more source

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review

Infectious Diseases and Therapy, 2019
Neisseria meningitidis is a major cause of meningitis and septicemia with cases, outbreaks, and epidemics reported globally in industrialized and non-industrialized countries. N. meningitidis is categorized into 12 serogroups; however, only 5 serogroups (
Jessica Presa, Jamie Findlow, Jelena Vojicic, Scott Williams, Lidia Serra   +4 more
doaj   +1 more source

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect

npj Vaccines, 2021
Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical manifestations, but the bacteria share up to 80–90% genome sequence identity.
Yara Ruiz García, Woo-Yun Sohn, Kate L. Seib, Muhamed-Kheir Taha, Julio A. Vázquez, Ana Paula S. de Lemos, Kumaran Vadivelu, Mariagrazia Pizza, Rino Rappuoli, Rafik Bekkat-Berkani   +9 more
doaj   +1 more source

Sequential and Concurrent C5 and Neonatal Fc Receptor Inhibition in Prolonged Myasthenic Crisis due to Advanced Invasive Thymoma‐Associated Myasthenia Gravis: A Case Report and Literature Review

Clinical and Experimental Neuroimmunology, Volume 17, Issue 4, November 2026.
ABSTRACT Thymoma‐associated myasthenia gravis (TAMG) is frequently refractory, particularly when complicated by myasthenic crisis in advanced invasive disease. Complement C5 inhibitors and neonatal Fc receptor (FcRn) inhibitors have expanded the treatment of acetylcholine receptor (AChR) antibody‐positive generalized myasthenia gravis; however, their ...
Yuta Kizuka, Yuriko Nakamura, Kensuke Okada, Yu Okubo, Kaoru Kaseda, Hirofumi Toyama, Keisuke Asakura, Atsuya Takeda, Jin Nakahara, Kei Ishizuchi   +9 more
wiley   +1 more source

Can near real-time monitoring of emergency department diagnoses facilitate early response to sporadic meningococcal infection? - prospective and retrospective evaluations

BMC Infectious Diseases, 2010
Background Meningococcal infection causes severe, rapidly progressing illness and reporting of cases is mandatory in New South Wales (NSW), Australia.
Zheng Wei, Muscatello David J, O'Toole Libby, Churches Tim   +3 more
doaj   +1 more source

Meningococcal disease and climate

Global Health Action, 2009
Invasive meningococcal disease (IMD) is an epidemic infectious disease highly influenced by climatic factors. Climate plays an important role in both the spatial distribution of the disease and in the seasonality of IMD as seen all over the world. It is mentioned as one of the infectious diseases likely to be affected by climate change in the Fourth ...
openaire   +2 more sources

Achieving Cancer Prevention Equity: A Policy Analysis of American Cancer Society HPV Vaccination Guidelines

Journal of Advanced Nursing, Volume 82, Issue 10, Page 9384-9398, October 2026.
ABSTRACT Aim To examine the American Cancer Society's HPV vaccination guidelines through a nursing policy analysis framework, assessing justice and equity outcomes in cancer prevention policy implementation. Background Human papillomavirus vaccination remains critical for cancer prevention, yet persistent health disparities undermine equity goals ...
Grace K. Kyei, Evans K. Kyei, Rockson Ansong   +2 more
wiley   +1 more source